背景 1999年的医疗协会组织了如何减少医疗事故,保障病人安全的讨论。目前,美国还没有一个标准化的系统用来收集和评估输血医疗中的过失,对过失的报道或对输血过失报道的态度还知之甚少。方法 给3,669所美国非政府经营的,调查者认为涉及输血的医院发去邮件调查信,该调查先于2001年FDA(食品及药物管理局)需要报告生物制品差错规定。输血机构报告错误程序、适应标准化报告制度的意见和把过失报告给第三 Background The Medical Association of 1999 organized a discussion on how to reduce medical accidents and ensure patient safety. At present, the United States does not yet have a standardized system for collecting and assessing transfusions in transfusion medicine, and little is known about the reports of negligence or the reporting of transfusion failures. METHODS: A total of 3,669 U.S. non-governmental hospitals that investigators believe involved blood transfusions were sent mail investigation letters prior to the 2001 FDA (Food and Drug Administration) reporting of biological product errors. Blood transfusion agencies report wrong procedures, adapt to standardized reporting systems, and report misconduct to third